Post-Stroke Facial Palsy — Rehabilitation & Treatment Guide — Cost, Top Hospitals & Success Rates | MyMedicPlus

Facial weakness following stroke is among the most immediately visible and psychosocially distressing consequences of cerebrovascular injury. It affects approximately 50–70% of acute stroke patients to some degree and profoundly impacts facial expression, speech articulation, swallowing, oral competence, and social identity. Understanding the distinct anatomy of facial motor pathways is fundamental to accurate diagnosis and appropriate rehabilitation planning.

Central (UMN) facial palsy — the predominant pattern in stroke — results from lesions in the contralateral motor cortex (precentral gyrus), corticobulbar tract, internal capsule, or brainstem above the facial nucleus. Crucially, the upper face (forehead, orbicularis oculi) receives bilateral cortical representation — fibres from both hemispheres converge on the upper facial nerve nucleus. Therefore, a unilateral stroke produces contralateral lower facial weakness with forehead sparing — the patient can wrinkle their forehead voluntarily on both sides but has marked weakness of the contralateral nasolabial fold and corner of the mouth.

Peripheral (LMN) facial palsy — exemplified by Bell's palsy (idiopathic peripheral seventh nerve palsy) — affects the facial nerve nucleus in the pons or the nerve itself, disrupting all ipsilateral facial motor fibres. The entire ipsilateral face is affected, including the forehead — the patient cannot wrinkle their forehead on the affected side. Additional features include ipsilateral reduced lacrimation (involvement of greater petrosal nerve), hyperacusis (involvement of nerve to stapedius), and loss of taste on the anterior two-thirds of the tongue (chorda tympani involvement).

The NIHSS (National Institutes of Health Stroke Scale) facial palsy item scores facial weakness on a 4-point scale: 0 = normal; 1 = minor (asymmetry of NLF, asymmetric smile); 2 = partial (complete or near-complete paralysis of lower face, some movement of upper face); 3 = complete (total unilateral or bilateral palsy). This score guides rehabilitation intensity and prognosis.

Post-stroke facial rehabilitation addresses a spectrum of functional deficits and secondary complications:

• Voluntary movement weakness: Reduced or absent voluntary movement of the ipsilateral lower face, cheek, lip, and perioral musculature — impairing speech articulation, smiling, eating, and emotional expression.
• Oral incompetence: Inability to seal the lips fully leads to drooling (sialorrhoea), difficulty drinking from a cup, and food spillage from the mouth — significant functional and psychosocial problems.
• Dysarthria: Facial and lingual weakness contributes to slurred or imprecise articulation (flaccid or spastic dysarthria), impairing speech intelligibility.
• Dysphagia: Reduced labial and buccal tone affects the oral preparatory phase of swallowing, increasing risk of aspiration.
• Spasticity and hypertonicity: In the subacute and chronic phases, UMN lesions can produce facial spasticity — involuntary contractions, resistance to passive movement, and resting muscle hypertonicity affecting the lower face.
• Synkinesis (mass movement patterns): More characteristic of recovering peripheral facial palsy (Bell's palsy) than central stroke, synkinesis involves involuntary co-contraction — e.g., eye closure triggering mouth movement (gustatolacrimal reflex) — resulting from aberrant reinnervation. Can develop in incomplete recovery from central palsy as cortical plasticity reorganises motor maps.
• Psychological and social impact: Visible facial asymmetry causes depression, social withdrawal, and reduced quality of life. Fear of being perceived negatively significantly reduces participation in rehabilitation activities and social reintegration.

Virtually all patients with clinically significant post-stroke facial weakness benefit from structured rehabilitation input, with the intensity and modality tailored to stroke severity, chronicity, and individual functional goals. Specific considerations include:

• Acute phase (0–2 weeks): Even in the hyperacute period, early facial physiotherapy (passive movement, education on oral hygiene and saliva management) and SLT (speech and language therapy) assessment of dysarthria and dysphagia are recommended within 24–48 hours of admission as per national stroke guidelines.
• Subacute phase (2 weeks–6 months): The greatest period of neurological recovery and most responsive to intensive rehabilitation. Mirror therapy, neuromuscular electrical stimulation (NMES), and neurofacilitation techniques are most effective during this window of heightened cortical plasticity.
• Chronic phase (>6 months): Patients with persisting weakness still benefit from rehabilitation but require management of secondary complications — spasticity, synkinesis, contracture, and psychological adaptation. Botulinum toxin A is particularly relevant in this phase.
• Eligibility criteria for botulinum toxin (BTX-A): Botulinum toxin injection is indicated for post-stroke facial spasticity or synkinesis when: involuntary movements or spasticity impair function or quality of life, conservative physiotherapy has been maximised, and the patient has no contraindications (neuromuscular junction disease, aminoglycoside therapy, pregnancy).
• Cognitive capacity: Many rehabilitation techniques (mirror therapy, NMES biofeedback) require patient engagement and understanding. Concomitant aphasia, cognitive impairment, or reduced consciousness requires adaptation of rehabilitation approach and caregiver involvement.

Neurofacilitation Techniques:

• Bobath concept (Neuro-Developmental Treatment — NDT): A neurophysiological approach that uses handling techniques to facilitate normal movement patterns and inhibit abnormal tone. In facial rehabilitation, NDT-trained therapists use specific facilitation of lip, cheek, and oral musculature through proprioceptive inputs, placing hands to guide normal movement trajectories.
• Proprioceptive Neuromuscular Facilitation (PNF): Uses diagonal movement patterns, stretch reflexes, and resistance to facilitate neuromuscular recruitment. Applied to facial muscles through structured resistance patterns to activate weakened motor units.

Mirror Therapy: The patient observes their unaffected face in a mirror placed sagittally, creating a visual illusion that the affected side is moving normally while performing facial exercises. This technique exploits visual-motor integration and mirror neuron systems to drive cortical reorganisation in the affected hemisphere. Multiple small RCTs demonstrate benefit for hand and limb motor recovery post-stroke; evidence for facial application is growing, particularly for lower facial weakness. Typically performed in 15–30 minute daily sessions over 4–8 weeks.

Neuromuscular Electrical Stimulation (NMES) and Electromyographic Biofeedback:

• NMES (e.g., NeuroMove device): Surface electrodes deliver low-level electrical stimulation to target facial muscles, triggering motor unit firing and assisting voluntary movement. EMG-triggered NMES (contingent on patient effort) maximises motor learning by timing stimulation to the patient's intentional movement attempt — coupling volition with muscle activation. Evidence from multiple RCTs supports NMES over standard care for improving facial motor scores.
• EMG biofeedback: Real-time visual or auditory feedback of muscle electrical activity helps patients learn to selectively activate weakened muscles with greater precision and confidence than observation alone allows.

Botulinum Toxin A (BTX-A): Chemodenervation with BTX-A (Botox, Dysport, Xeomin) is used in post-stroke facial management for: spasticity reduction in the lower facial muscles reducing involuntary contractions and resting hypertonicity; synkinesis management — targeted injection of co-contracting muscles (e.g., periocular muscles triggering perioral movement) breaks the abnormal co-contraction pattern, restoring selective muscle control. Effects last 3–4 months; repeated injections may be required.

Mime Therapy: A structured physiotherapy programme developed for peripheral facial palsy (Bell's palsy) comprising facial relaxation, emotional expression exercises, mime-based movement rehearsal, and inhibition of synkinetic movements. RCT evidence (van Swearingen, Brach) supports Mime Therapy as superior to conventional physiotherapy for incomplete peripheral facial palsy. Applicability to post-stroke central palsy is emerging.

Speech and Language Therapy: SLT targets dysarthria through articulatory exercises (lip rounding, bilabial plosives), oral motor strengthening, and compensatory communication strategies. Dysphagia management includes texture modification, postural strategies, and swallowing exercises.

Post-stroke facial rehabilitation, when initiated early and delivered with sufficient intensity, produces clinically meaningful functional and psychosocial benefits:

• Spontaneous neurological recovery: Approximately 70% of patients show meaningful functional improvement in facial weakness by 3 months post-stroke, driven by resolution of perilesional oedema, ischaemic penumbra rescue, and cortical plasticity. Rehabilitation accelerates and maximises this natural recovery trajectory.
• Improved voluntary movement: NMES, EMG biofeedback, and neurofacilitation techniques improve NIHSS facial scores, voluntary range of motion, and selective muscle control beyond what spontaneous recovery alone achieves.
• Oral function and drooling: Targeted lip and oral musculature rehabilitation significantly reduces drooling, improves oral seal for drinking and eating, and reduces aspiration risk — key functional gains with direct impact on independence and dignity.
• Speech intelligibility: Oral motor exercises and SLT input improve labial sound production (/b/, /p/, /m/, /f/, /v/) and overall intelligibility for patients with facial-related dysarthria.
• BTX-A for spasticity/synkinesis: Chemodenervation produces objective reductions in House-Brackmann facial grade, patient-reported interference from involuntary movements, and improved composite facial movement scores when repeated in maintenance cycles.
• Psychological wellbeing: Improvement in visible facial symmetry is directly associated with reduced depression scores, improved self-esteem, willingness to socialise, and return to pre-stroke social roles.

Post-stroke facial rehabilitation is generally safe, but specific techniques carry individual risk profiles:

• NMES adverse effects: Skin irritation, redness, or mild discomfort at electrode sites. Contraindicated in patients with implanted cardiac devices (pacemakers, ICDs), metal implants in the treatment area, active skin infections, and epilepsy (though facial NMES is low risk for seizure provocation). Caution in patients with impaired sensation who cannot report discomfort.
• Botulinum toxin injection risks: Ptosis (eyelid drooping) and lagophthalmos (incomplete eye closure) are the most clinically significant complications of periocular BTX-A injection — careful technique and dosing reduce risk. Brow ptosis, asymmetric smile (over-treatment of normal side), and haematoma at injection sites. Temporary dysphagia is possible with injection near the masseter or submandibular region. All effects are temporary (3–4 months) but require management in the interim.
• Mirror therapy limitations: Not effective in patients with significant visuospatial neglect, hemianopia, or severe cognitive impairment. Compliance requires patient motivation and insight.
• Overtreatment risk: Excessive facial exercises without proper neurofacilitation guidance can reinforce abnormal movement patterns, synkinesis, and spasticity — particularly in recovering peripheral palsy. Exercises should be guided by a trained neurological physiotherapist, not self-directed from generic internet resources.
• Realistic expectations: Not all patients achieve full facial recovery. Severe initial facial palsy, large cortical lesions, brainstem infarction, and advanced age reduce recovery prognosis. Psychological preparation for partial outcomes is an important component of rehabilitation planning.

Post-stroke facial recovery is a prolonged process requiring structured follow-up across the rehabilitation continuum:

• Acute inpatient phase: Daily physiotherapy and SLT assessment. Standardised facial motor grading (NIHSS, House-Brackmann scale, Sunnybrook Facial Grading System) at admission, weekly, and discharge. Dysphagia screening within 4 hours of stroke admission (NIHSS-based, bedside water swallow test, formal videofluoroscopy if indicated).
• Early supported discharge and community rehabilitation: Continuation of home-based mirror therapy and NMES programmes with weekly therapist review. SLT input for dysarthria and dysphagia management. Regular re-evaluation of facial motor recovery using standardised measures (Sunnybrook FGS — generates a composite score accounting for resting symmetry, voluntary movement, and synkinesis).
• 3-month review: Formal reassessment of recovery. Introduction of BTX-A if spasticity or synkinesis is impairing function. Transition from facilitation-based to strengthening and coordination-based exercises as voluntary control improves.
• 6-month and annual review: Assessment of residual deficits. Ongoing BTX-A maintenance injections every 3–4 months if beneficial. Psychological reassessment and referral to clinical psychology for persistent adjustment difficulties, body image concerns, or depression.
• Specialist liaison: Ophthalmology referral if incomplete eye closure (lagophthalmos) risks corneal exposure keratopathy — lubricating eye drops, moisture chamber glasses, or surgical correction (gold weight upper lid loading) may be required for severe persistent lagophthalmos.

The cost of post-stroke facial rehabilitation is determined by treatment setting, technique complexity, and duration of the rehabilitation programme:

• NHS inpatient rehabilitation (UK): Physiotherapy, SLT, and multidisciplinary stroke rehabilitation are core NHS services for stroke patients, funded within the acute and rehabilitation hospital tariff. Hyper-acute stroke units (HASUs) and dedicated stroke rehabilitation units provide intensive, specialised care.
• Outpatient and community physiotherapy: NHS community physiotherapy availability varies significantly by region. Some patients face long waiting lists (12–26 weeks) — private physiotherapy (£60–£120 per session) is used by those who can afford it to maintain treatment momentum.
• Botulinum toxin injections: NHS-funded in specialist spasticity clinics meeting defined criteria. In private practice, BTX-A injections for facial spasticity/synkinesis cost £300–£600 per session (including drug cost). Repeated injections every 3–4 months accumulate significant annual cost.
• NMES devices: The NeuroMove device (and similar) is available for home use; rental programmes cost approximately £150–£300 per month. Some rehabilitation centres include NMES in their programme cost.
• Medical tourism for stroke rehabilitation: Specialist neurological rehabilitation centres in India (e.g., NIMHANS, Apollo Hospitals), Turkey, and Germany offer structured post-stroke rehabilitation programmes at 40–70% less than comparable UK private rates. A 4-week intensive inpatient rehabilitation programme in India may cost £3,000–£6,000 vs £15,000–£25,000 in the UK privately.
• Hidden costs: Travel to appointments (particularly relevant for community-dwelling patients with reduced mobility), carer time, and assistive devices (NMES units, communication aids, adapted cutlery for oral motor impairment) represent significant indirect costs that should be incorporated into financial planning.

Beyond mainstream rehabilitation, several complementary and alternative approaches are used or investigated for post-stroke facial recovery:

• Acupuncture: Among the most studied complementary interventions for post-stroke rehabilitation. Several RCTs from China report improved facial motor scores with acupuncture at specific facial and distal points (ST4, ST6, ST7, LI4, LR3). Systematic reviews show heterogeneous results; Cochrane analysis is inconclusive due to methodological limitations. Acupuncture is offered within some NHS stroke services as a complementary adjunct and is generally safe when performed by trained practitioners.
• Transcranial Magnetic Stimulation (TMS) and tDCS: Non-invasive brain stimulation techniques applied to the affected motor cortex to enhance cortical excitability and drive neuroplasticity. Both repetitive TMS (rTMS) and transcranial direct current stimulation (tDCS) have emerging evidence for upper and lower limb recovery; facial-specific applications are being investigated. Not yet standard of care but available in specialist research centres.
• Constraint-induced movement therapy (CIMT) adapted for face: Theoretical application of CIMT principles — restraining the unaffected side to force use of the affected side — has been explored in facial rehabilitation protocols but evidence is limited.
• Tai Chi and Yoga: Body-mind practices with evidence for general wellbeing, mood, and balance post-stroke. No specific evidence for facial recovery but may improve overall rehabilitation engagement and psychological resilience.
• Psychological therapy (CBT, ACT): Cognitive Behavioural Therapy and Acceptance and Commitment Therapy have strong evidence for managing post-stroke depression and anxiety, which directly facilitates engagement with physical rehabilitation. Not an alternative to physiotherapy but an essential complementary strand for holistic recovery.
• Facial prosthetics and cosmetic approaches: For severe persistent asymmetry, cosmetic procedures (filler injections to flatten NLF on unaffected side, surgical suspension of ptotic lip corner) may be considered in stable chronic cases to improve resting facial symmetry — generally considered only after 12–18 months when neurological recovery has plateaued.